Loading...
Influence of age on the occurrence of adverse events in rheumatic patients at the onset of biological treatment: data from the BIOBADASER III register
OBJECTIVES: To assess whether age, at the beginning of biologic treatment, is associated with the time a first adverse event (AE) appears in patients with rheumatoid arthritis (RA), ankylosing spondylitis (AS), or psoriatic arthritis (PsA). METHODS: All patients in the BIOBADASER registry diagnosed...
Na minha lista:
| Udgivet i: | Arthritis Res Ther |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7296933/ https://ncbi.nlm.nih.gov/pubmed/32539800 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-020-02231-x |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|